ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Frequency Therapeutics to Present at the 14th Stem Cell Research and Regenerative Medicine Conference – Yahoo Finance

Continue reading

2017-04-05 Michael Zand NEWS

Endocyte Presents Data at AACR Identifying Multiple Methods for Managing Severe Side Effects Resulting from CAR T … – GlobeNewswire (press release)

Frequency Therapeutics to Present at the 14th Stem Cell Research and Regenerative Medicine Conference
Yahoo Finance
Frequency Therapeutics, a company spearheading the movement to restore hearing by harnessing the regenerative potential of progenitor cells in the body, today announced that Chris Loose, Ph.D., the Company’s Co-founder and Chief Scientific Officer …

and more »

Continue reading

2017-04-05 Michael Zand NEWS

UMD Team Reverses Paralysis in MS Mouse Model Using Novel Immunotherapy Strategy – Multiple Sclerosis News Today

Multiple Sclerosis News TodayUMD Team Reverses Paralysis in MS Mouse Model Using Novel Immunotherapy StrategyMultiple Sclerosis News TodayIn MS, the immune system turns against healthy body tissue and targets the myelin protective sheath surrounding ne… Continue reading

2017-04-05 Michael Zand NEWS

New immunotherapy combination shows promise for patients with advanced melanoma – Medical Xpress

New immunotherapy combination shows promise for patients with advanced melanomaMedical XpressTreatment with a combination of ipilimumab (Yervoy) and Coxsackievirus A21 (CVA21; Cavatak) led to durable responses in a number of patients with advanced mela… Continue reading

2017-04-05 Michael Zand NEWS

Stem cells offer hope for autism – fox6now.com

fox6now.comStem cells offer hope for autismfox6now.comEven Duke researchers acknowledge as much. The initial trial, published Wednesday in the journal Stem Cells Translational Medicine, was a safety study, not a controlled, double-blind study with defi… Continue reading

2017-04-05 Michael Zand NEWS

Abeona Announces Rare Disease Gene Therapy Symposium with the New York Academy of Sciences – Yahoo Finance

Endocyte Presents Data at AACR Identifying Multiple Methods for Managing Severe Side Effects Resulting from CAR T …
GlobeNewswire (press release)
“The significant potential of CAR T-cell therapies has been limited by an inability to control the rate and degree of cytokine release, which can cause severe safety issues in patients. The data presented demonstrate approaches that may successfully …

and more »

Continue reading

2017-04-05 Michael Zand NEWS

Abeona Announces Rare Disease Gene Therapy Symposium with … – Nasdaq

Abeona Announces Rare Disease Gene Therapy Symposium with …NasdaqCompany CEO to Co-Chair Symposium being held on April 11 th in NYC. NEW YORK and CLEVELAND, April 05, 2017– Abeona Therapeutics Inc., a leading.and more &raquo… Continue reading

2017-04-05 Michael Zand NEWS

Abeona Announces Rare Disease Gene Therapy Symposium with … – GlobeNewswire (press release)

Abeona Announces Rare Disease Gene Therapy Symposium with …GlobeNewswire (press release)NEW YORK and CLEVELAND, April 05, 2017 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical …and more&nbs… Continue reading

2017-04-05 Michael Zand NEWS
  • 1
  • …
  • 1,882
  • 1,883
  • 1,884
  • 1,885
  • 1,886
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Abeona Announces Rare Disease Gene Therapy Symposium with the New York Academy of Sciences
Yahoo Finance
“We are pleased to co-host this unique gene therapy symposium that highlights the importance of outcome measurements in gene therapy trial design, preclinical strategies, new clinical redosing paradigms and combination approaches for treating rare …

and more »